(PDF) Remitting–relapsing Multiple Sclerosis Patient

Remitting–relapsing Multiple Sclerosis Patient Refractory to Conventional Treatments and Bone Marrow Transplantation Who Responded to Natalizumab

International Journal of General Medicine - New Zealand

doi 10.2147/ijgm.s13648

Full Text

Abstract

Available in full text

Categories

Date

September 1, 2010

Authors

Athanasia Mouzaki

Publisher

Informa UK Limited

Related search

Natalizumab: A New Treatment for Relapsing Remitting Multiple Sclerosis

Therapeutics and Clinical Risk Management

Chemical Health

Safety Research

English

Disease-Modifying Therapies in Relapsing–remitting Multiple Sclerosis

Neuropsychiatric Disease and Treatment

Biological Psychiatry

English

Alemtuzumab: Evidence for Its Potential in Relapsing–remitting Multiple Sclerosis

Drug Design, Development and Therapy

Pharmaceutical Science

English

Real-Life Effectiveness of Natalizumab in Relapsing-Remitting Multiple Sclerosis (Rrms): A Registry Analysis

Value in Health

Occupational Health

English

Efficacy of Natalizumab and Fingolimod in Relapsing Remitting Multiple Sclerosis in Real World Clinical Setting

Journal of Neurology & Neurophysiology

English

Pnd12 - Natalizumab Versus Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis: A Network Meta-Analysis

Value in Health

Occupational Health

English

Long-Term Evaluation of NEDA-3 Status in Relapsing-Remitting Multiple Sclerosis Patients After Switching From Natalizumab to Fingolimod

Therapeutic Advances in Neurological Disorders

English

Intestinal Permeability in Relapsing-Remitting Multiple Sclerosis

Neurotherapeutics

English

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis

Archives of Neurology

English